
Paul Martens Janeski
Examiner (ID: 4040, Phone: (571)270-1681 , Office: P/3722 )
| Most Active Art Unit | 3722 |
| Art Unit(s) | 3726, 3722 |
| Total Applications | 635 |
| Issued Applications | 463 |
| Pending Applications | 0 |
| Abandoned Applications | 175 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19536741
[patent_doc_number] => 12129282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Factor H binding protein variants and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/316594
[patent_app_country] => US
[patent_app_date] => 2023-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 40
[patent_no_of_words] => 28784
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18316594
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/316594 | Factor H binding protein variants and methods of use thereof | May 11, 2023 | Issued |
Array
(
[id] => 18752495
[patent_doc_number] => 20230355751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => COMPOSITIONS AND METHODS FOR A MULTI-ADJUVANT ONLY APPROACH TO IMMUNOPROPHYLAXIS FOR PREVENTING INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/142216
[patent_app_country] => US
[patent_app_date] => 2023-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9895
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18142216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/142216 | COMPOSITIONS AND METHODS FOR A MULTI-ADJUVANT ONLY APPROACH TO IMMUNOPROPHYLAXIS FOR PREVENTING INFECTIONS | May 1, 2023 | Abandoned |
Array
(
[id] => 18724280
[patent_doc_number] => 20230338414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => USE OF TLR4 MODULATOR IN THE TREATMENT OF COCCIDIOSIS
[patent_app_type] => utility
[patent_app_number] => 18/139749
[patent_app_country] => US
[patent_app_date] => 2023-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18139749
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/139749 | USE OF TLR4 MODULATOR IN THE TREATMENT OF COCCIDIOSIS | Apr 25, 2023 | Pending |
Array
(
[id] => 19035600
[patent_doc_number] => 20240085415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => EXTRACTION REAGENT FOR USE IN AN ASSAY FOR DETECTION OF GROUP A STREPTOCOCCUS
[patent_app_type] => utility
[patent_app_number] => 18/307749
[patent_app_country] => US
[patent_app_date] => 2023-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18307749
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/307749 | EXTRACTION REAGENT FOR USE IN AN ASSAY FOR DETECTION OF GROUP A STREPTOCOCCUS | Apr 25, 2023 | Pending |
Array
(
[id] => 18769453
[patent_doc_number] => 20230364217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => Influenza vaccine, composition, and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/303512
[patent_app_country] => US
[patent_app_date] => 2023-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18303512
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/303512 | Influenza vaccine, composition, and methods of use | Apr 18, 2023 | Abandoned |
Array
(
[id] => 19300377
[patent_doc_number] => 20240228946
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => RECOMBINANT MICROORGANISM INCLUDING GENETIC MODIFICATION THAT INCREASES EXPRESSION OF IRON STORAGE PROTEIN WITH HEME STRUCTURE, AND METHOD OF REDUCING CONCENTRATION OF NITROGEN OXIDE IN SAMPLE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/301389
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301389
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/301389 | RECOMBINANT MICROORGANISM INCLUDING GENETIC MODIFICATION THAT INCREASES EXPRESSION OF IRON STORAGE PROTEIN WITH HEME STRUCTURE, AND METHOD OF REDUCING CONCENTRATION OF NITROGEN OXIDE IN SAMPLE USING THE SAME | Apr 16, 2023 | Pending |
Array
(
[id] => 19300377
[patent_doc_number] => 20240228946
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => RECOMBINANT MICROORGANISM INCLUDING GENETIC MODIFICATION THAT INCREASES EXPRESSION OF IRON STORAGE PROTEIN WITH HEME STRUCTURE, AND METHOD OF REDUCING CONCENTRATION OF NITROGEN OXIDE IN SAMPLE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/301389
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301389
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/301389 | RECOMBINANT MICROORGANISM INCLUDING GENETIC MODIFICATION THAT INCREASES EXPRESSION OF IRON STORAGE PROTEIN WITH HEME STRUCTURE, AND METHOD OF REDUCING CONCENTRATION OF NITROGEN OXIDE IN SAMPLE USING THE SAME | Apr 15, 2023 | Pending |
Array
(
[id] => 19578754
[patent_doc_number] => 12144836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Probiotics and probiotic compositions for regulating body weight
[patent_app_type] => utility
[patent_app_number] => 18/122835
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 28
[patent_no_of_words] => 16372
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122835
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122835 | Probiotics and probiotic compositions for regulating body weight | Mar 16, 2023 | Issued |
Array
(
[id] => 18675088
[patent_doc_number] => 20230312661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => NON-NEURONAL SNARE-CLEAVING BOTULINUM NEUROTOXINS
[patent_app_type] => utility
[patent_app_number] => 18/184627
[patent_app_country] => US
[patent_app_date] => 2023-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18184627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/184627 | NON-NEURONAL SNARE-CLEAVING BOTULINUM NEUROTOXINS | Mar 14, 2023 | Abandoned |
Array
(
[id] => 18449425
[patent_doc_number] => 20230190701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Compounds for Treating Tauopathies and Restless Leg Syndrome and Methods of Using and Screening for Same
[patent_app_type] => utility
[patent_app_number] => 18/177471
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18177471
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/177471 | Compounds for Treating Tauopathies and Restless Leg Syndrome and Methods of Using and Screening for Same | Mar 1, 2023 | Pending |
Array
(
[id] => 18436005
[patent_doc_number] => 20230183299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Materials and Methods For Cell-Free Expression of Vaccine Epitope Concatemers
[patent_app_type] => utility
[patent_app_number] => 18/172378
[patent_app_country] => US
[patent_app_date] => 2023-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18172378
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/172378 | Materials and Methods For Cell-Free Expression of Vaccine Epitope Concatemers | Feb 21, 2023 | Abandoned |
Array
(
[id] => 18550839
[patent_doc_number] => 20230248839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => IMMUNOGENIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/109970
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109970
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/109970 | IMMUNOGENIC COMPOSITIONS | Feb 14, 2023 | Abandoned |
Array
(
[id] => 19970678
[patent_doc_number] => 12339281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Immunochromatographic kit and method for detecting mycobacterium tuberculosis
[patent_app_type] => utility
[patent_app_number] => 18/156214
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9322
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18156214
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/156214 | Immunochromatographic kit and method for detecting mycobacterium tuberculosis | Jan 17, 2023 | Issued |
Array
(
[id] => 18374446
[patent_doc_number] => 20230149525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => IMMUNOGENIC TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/154177
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154177
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154177 | IMMUNOGENIC TREATMENT OF CANCER | Jan 12, 2023 | Abandoned |
Array
(
[id] => 18626674
[patent_doc_number] => 20230285474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => NOVEL BIFIDOBACTERIUM BREVE IDCC 4401 STRAIN AND ITS DEAD CELL ID-BBR4401 HAVING EXCELLENT ACID TOLERANCE AND BILE TOLERANCE AND PROPHYLACTIC OR THERAPEUTIC EFFECT ON DYSLIPIDEMIA
[patent_app_type] => utility
[patent_app_number] => 18/148955
[patent_app_country] => US
[patent_app_date] => 2022-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18148955
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/148955 | NOVEL BIFIDOBACTERIUM BREVE IDCC 4401 STRAIN AND ITS DEAD CELL ID-BBR4401 HAVING EXCELLENT ACID TOLERANCE AND BILE TOLERANCE AND PROPHYLACTIC OR THERAPEUTIC EFFECT ON DYSLIPIDEMIA | Dec 29, 2022 | Pending |
Array
(
[id] => 19049363
[patent_doc_number] => 20240091332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => COMPOUNDS AND METHODS FOR BIOFILM DISRUPTION AND PREVENTION
[patent_app_type] => utility
[patent_app_number] => 18/069759
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069759
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/069759 | COMPOUNDS AND METHODS FOR BIOFILM DISRUPTION AND PREVENTION | Dec 20, 2022 | Abandoned |
Array
(
[id] => 18434362
[patent_doc_number] => 20230181656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => NOVEL LACTIC ACID BACTERIA AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/065497
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065497
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065497 | Lactic acid bacteria and use thereof | Dec 12, 2022 | Issued |
Array
(
[id] => 19743996
[patent_doc_number] => 20250032561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => LACTOBACILLI FOR SKIN AGING
[patent_app_type] => utility
[patent_app_number] => 18/714926
[patent_app_country] => US
[patent_app_date] => 2022-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18714926
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/714926 | LACTOBACILLI FOR SKIN AGING | Nov 24, 2022 | Pending |
Array
(
[id] => 19657012
[patent_doc_number] => 20240424077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => A METHOD TO PRODUCE A VACCINE AGAINST STREPTOCOCCUS SUIS AND THE SAID VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/708248
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18708248
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/708248 | A METHOD TO PRODUCE A VACCINE AGAINST STREPTOCOCCUS SUIS AND THE SAID VACCINE | Nov 16, 2022 | Pending |
Array
(
[id] => 18244843
[patent_doc_number] => 20230077154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => TREATMENT OF CIRRHOSIS USING BOTULINUM TOXIN
[patent_app_type] => utility
[patent_app_number] => 17/987675
[patent_app_country] => US
[patent_app_date] => 2022-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17987675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/987675 | TREATMENT OF CIRRHOSIS USING BOTULINUM TOXIN | Nov 14, 2022 | Pending |